SCHEMBL9165

SCHEMBL9165

CC(N)c1cc2ccccc2nc1N1CC[N]CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.44
ALDH1A1 P00352 8/20 0.43
KDM4E B2RXH2 6/20 0.43
TDP1 Q9NUW8 5/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
MAPT P10636 5/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
BCL2 P10415 2/20 0.41
MCL1 Q07820 2/20 0.41
BCL2A1 Q16548 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
MAPK1 P28482 3/20 0.39
TSHR P16473 2/20 0.39
CASP1 P29466 2/20 0.39
CASP7 P55210 1/20 0.39
GFER P55789 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2115704 0.81 NCF1 (0.49) PIK3CDALDH1A1KDM4ETDP1MAPT
SCHEMBL2115701 0.81 NCF1 (0.49) PIK3CDALDH1A1KDM4ETDP1MAPT
SCHEMBL15865468 0.72 PIK3CD (0.57) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL22263486 0.71 POLB (0.56) ALDH1A1KDM4ETDP1L3MBTL1MAPT
SCHEMBL14872902 0.71 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1MAPTHPGD
SCHEMBL22198990 0.69 EGFR (0.50) PIK3CDALDH1A1KDM4ETDP1MAPT
SCHEMBL845236 0.69 ALOX15 (0.59) PIK3CDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL715736 0.69 ALOX15 (0.59) PIK3CDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL715249 0.68 HPGD (0.43) PIK3CDALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL20061318 0.67 PDE10A (0.57) ALDH1A1KDM4ETDP1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011058109-A1 FUSED BICYCLIC PYRROLE AND IMIDAZOLE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2011-05-19 WO disclosed